Skip to main content
Alphanox Co.,Ltd. logo

Alphanox Co.,Ltd. — Investor Relations & Filings

Ticker · 043100 ISIN · KR7043100007 KO Manufacturing
Filings indexed 364 across all filing types
Latest filing 2025-09-03 Major Shareholding Noti…
Country KR South Korea
Listing KO 043100

About Alphanox Co.,Ltd.

https://alphanox.co.kr/en/

Alphanox Co.,Ltd., formerly known as Solco Biomedical, is a global medical and healthcare group established in 1974. The company specializes in the development, manufacturing, and sale of advanced medical devices and health-promoting products. Its primary product lines include surgical instruments, orthopedic implants with a strong focus on spinal applications, and in-vitro diagnostic devices. In addition to its core medical offerings, Alphanox also produces healthcare products such as functional water and other health-promoting devices. The company is committed to improving quality of life through extensive research and development grounded in medical engineering and clinical results.

Recent filings

Filing Released Lang Actions
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from the Korean Exchange (KRX) system (indicated by the 'kind.krx.co.kr' links) detailing a 'Change in Largest Shareholder' (최대주주변경). This type of disclosure is a standard regulatory requirement for public companies to report significant changes in ownership structure. Since it does not fit into specific categories like 'Director's Dealing' (which is for individual insider trades) or 'Major Shareholding Notification' (which is usually for external investors reporting their own holdings), it falls under the general regulatory filing category.
2025-09-03 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) for the company AlphaNox (now AlphaAI). It details the amendment of terms for a third-party capital increase, including changes to the payment date, listing date, and use of funds. This type of filing is a standard regulatory disclosure for capital structure changes and share issuance in the Korean market, which falls under the 'Share Issue/Capital Change' category.
2025-08-28 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and specifically acts as a 'Correction Report' (정정신고) for a previously filed document. It details changes to bond maturity dates, interest payment schedules, conversion prices, and other financial terms. This type of regulatory filing for capital structure changes, specifically convertible bond issuance, falls under the 'Capital/Financing Update' category.
2025-08-28 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정) and is explicitly labeled as a 'Correction Report' (정정신고). It details changes to bond maturity, interest payment dates, conversion prices, and other financial terms. This type of filing, which details capital structure changes and financing activities, falls under the 'Capital/Financing Update' category.
2025-08-27 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '알파녹스' (now '알파AI') for the period ending June 30, 2025. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정) and specifically acts as an amendment (정정신고) to a previously filed report. It details changes to interest rates, redemption methods, and put option terms for convertible bonds. In the context of Korean financial filings (DART), this is a standard regulatory filing for capital structure changes and financing activities. It fits the 'Capital/Financing Update' category.
2025-08-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.